Header Logo

Connection

Kristi Reynolds to Heart Failure

This is a "connection" page, showing publications Kristi Reynolds has written about Heart Failure.
Connection Strength

2.431
  1. Representativeness of the GALACTIC-HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2022 Apr 05; 11(7):e023766.
    View in: PubMed
    Score: 0.565
  2. Reply: To PMID 26361825. Am J Cardiol. 2015 Nov 01; 116(9):1486.
    View in: PubMed
    Score: 0.358
  3. Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality. Am J Cardiol. 2015 Aug 01; 116(3):400-5.
    View in: PubMed
    Score: 0.351
  4. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181.
    View in: PubMed
    Score: 0.146
  5. Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions. JAMA Netw Open. 2022 04 01; 5(4):e228031.
    View in: PubMed
    Score: 0.141
  6. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy. Pharmacoepidemiol Drug Saf. 2021 12; 30(12):1630-1634.
    View in: PubMed
    Score: 0.137
  7. Noncardiac-Related Morbidity, Mobility Limitation, and Outcomes in Older Adults With Heart Failure. J Gerontol A Biol Sci Med Sci. 2020 09 25; 75(10):1981-1988.
    View in: PubMed
    Score: 0.127
  8. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99.
    View in: PubMed
    Score: 0.123
  9. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
    View in: PubMed
    Score: 0.104
  10. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
    View in: PubMed
    Score: 0.097
  11. Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction. Am J Cardiol. 2015 Oct 01; 116(7):1088-92.
    View in: PubMed
    Score: 0.089
  12. Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail. 2014 Jan; 7(1):21-7.
    View in: PubMed
    Score: 0.080
  13. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins. JAMA Netw Open. 2020 01 03; 3(1):e1918554.
    View in: PubMed
    Score: 0.030
  14. Age and sex differences in long-term outcomes following implantable cardioverter-defibrillator placement in contemporary clinical practice: findings from the Cardiovascular Research Network. J Am Heart Assoc. 2015 Jun 02; 4(6):e002005.
    View in: PubMed
    Score: 0.022
  15. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015 Sep; 88(3):622-32.
    View in: PubMed
    Score: 0.022
  16. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. Diabetes Care. 2015 May; 38(5):905-12.
    View in: PubMed
    Score: 0.022
  17. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011 Mar 02; 305(9):913-22.
    View in: PubMed
    Score: 0.016

© 2024 Kaiser Permanente